Abstract: Several reports have demonstrated difficulties and lack of agreement in the histopathological diagnosis of particular melanocytic lesions, with problems in their management. A histogenetic approach to the study of these lesions originated the following classification: 1. superficial atypical proliferation significance; 2. melanocytic tumor of uncertain potential; 3. pigmented epithelioid melanocitoma of uncertain potential; 4. microinvasive radial growth phase of uncertain potential. The terminology remains controversial, reflecting the uncertainty of the diagnosis and the biological potential of these atypical melanocytic lesions.
Although precise histopathological criteria for distinguishing benign from malignant melanocytic lesions have already been established, a precise diagnosis is not always possible. This problem is reflected in the use of various terms coined over the years, such as 'atypical', 'ambiguous' and 'borderline'. 1, 2 The term "atypical melanocytic proliferation of uncertain (oncogenic) biological significance" is the most appropriate terminology to categorize melanocytic proliferations that cannot be classified as benign or malignant. Such a diagnostic uncertainty should be communicated clearly and directly to physicians and to their patients in the histological report. Indeed, such communication is necessary to ensure patients are offered appropriate management options.
Based on the histogenesis of melanocytic lesions, pathologists can classify the lesions into four categories: report, lesions considered in the differential diagnosis must be described so that an optimal, definitive treatment can be performed.
A SAMPUS is characterized by focal invasion of papillary dermis without evidence of tumorigenic nodule and mitogenicity.
Consequently, the lesion is not associated with competence for metastasis, and the prognosis is excellent after complete excision of the lesion. 4 This last lesion is similar to the pigmented epithelioid melanocitoma described by Zembowicz at al. 5 In the series of cases analyzed by these authors, the incidence of sentinel lymph node involvement was found in 41% of all cases. The behavior of these lesions is potentially malignant, but features allowing a conclusive diagnosis related to melanocytic malignant tumors are very difficult to find. For this reason, we prefer to use the term PEMUMP. All clinical-pathological attributes and the potential malignant nature of the lesion must be described in the histological report.
In conclusion, this histogenetic categorization of melanocytic borderline tumors should be reported in WHO melanoma classification. 7-10 q
